Correlation Between Unicycive Therapeutics and Pliant Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Pliant Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Pliant Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Pliant Therapeutics, you can compare the effects of market volatilities on Unicycive Therapeutics and Pliant Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Pliant Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Pliant Therapeutics.

Diversification Opportunities for Unicycive Therapeutics and Pliant Therapeutics

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Unicycive and Pliant is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Pliant Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant Therapeutics and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Pliant Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant Therapeutics has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Pliant Therapeutics go up and down completely randomly.

Pair Corralation between Unicycive Therapeutics and Pliant Therapeutics

Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.37 times more return on investment than Pliant Therapeutics. However, Unicycive Therapeutics is 1.37 times more volatile than Pliant Therapeutics. It trades about 0.37 of its potential returns per unit of risk. Pliant Therapeutics is currently generating about -0.01 per unit of risk. If you would invest  53.00  in Unicycive Therapeutics on September 12, 2024 and sell it today you would earn a total of  27.00  from holding Unicycive Therapeutics or generate 50.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Unicycive Therapeutics  vs.  Pliant Therapeutics

 Performance 
       Timeline  
Unicycive Therapeutics 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Unicycive Therapeutics are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Unicycive Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Pliant Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Pliant Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Pliant Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Unicycive Therapeutics and Pliant Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Unicycive Therapeutics and Pliant Therapeutics

The main advantage of trading using opposite Unicycive Therapeutics and Pliant Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Pliant Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant Therapeutics will offset losses from the drop in Pliant Therapeutics' long position.
The idea behind Unicycive Therapeutics and Pliant Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.